Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Based on the integrated biomedical platform, ncjh is committed to developing innovative drugs for malignant tumors and autoimmune diseases. In addition to the approval of the first innovative drug, obutinib, ncjh has built more than 10 balanced R & D pipelines, three of which are in clinical stage.
Author:
Ms. Yi
Phone/WhatsApp:
December 13, 2022
December 06, 2022
November 16, 2022
November 16, 2022
May 19, 2022
April 13, 2022
この仕入先にメール
Author:
Ms. Yi
Phone/WhatsApp:
December 13, 2022
December 06, 2022
November 16, 2022
November 16, 2022
May 19, 2022
April 13, 2022
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.